Data / Form D filings / Numerion Labs, Inc.
Numerion Labs, Inc.: Form D filings
Numerion Labs, Inc., a biotechnology company in San Francisco, CA, filed 4 Form D notices with the SEC between 2018 and 2026. The latest, on March 19, 2026, reports $19.8 million sold of a $35 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 250 SUTTER ST. SUITE 650, San Francisco, CA, 94108
- Phone
- (650) 449-7925
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1736153
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 19, 2026 | New notice | $35,000,000 | $19,794,945 | $15,205,055 | 5 | Mar 10, 2026 | sec.gov |
| Mar 14, 2025 | New notice | $50,000,000 | $44,282,650 | $5,717,350 | 19 | Mar 8, 2024 | sec.gov |
| Aug 11, 2020 | New notice | $126,999,992 | $123,010,086 | $3,989,906 | 25 | Jun 10, 2020 | sec.gov |
| Jul 2, 2018 | New notice | $51,492,758 | $51,492,758 | 31 | Feb 2, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Stephen Worland | Executive Officer, Director | |
| Izhar Wallach | Director | |
| Robert Mittendorff | Director | |
| Adam Seabrook | Director | |
| Linda Maxwell | Director | |
| Mike Varney | Director | |
| Yan Zhao | Executive Officer |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Mar 16, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Numerion Labs, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.